Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Creager

Showing results (151-160 of 703) with videos related to

Pageof 71
Sort By:
The American Journal of Cardiology|February 14, 2023
Association of Anticoagulation and Major Adverse Limb Events After Index Peripheral Endovascular InterventionNiveditta Ramkumar, Philip P Goodney, Mark A Creager, et al.
European Heart Journal|April 30, 2013
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IIJoshua A Beckman, Francesco Paneni, Francesco Cosentino, et al.
The Journal of Physical Chemistry. B|October 30, 2010
Effect of perfluoroalkyl chain length on proton conduction in fluoroalkylated phosphonic, phosphinic, and sulfonic acidsMahesha B Herath, Stephen E Creager, Alex Kitaygorodskiy, et al.
Circulation|October 1, 2003
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part IIThomas F Lüscher, Mark A Creager, Joshua A Beckman, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|September 24, 2010
Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery diseaseWilliam R Hiatt, Mark A Creager, Antonino Amato, et al.
The New England Journal of Medicine|October 27, 1988
Vascular response in diabetes with neuropathic foot lesionsJ S Stamler, M A Creager, J Loscalzo, et al.
Circulation|October 15, 1995
Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunctionJ M Hare, E Loh, M A Creager, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1992
A kinetic study of factor I-mediated modification and release of RBC-bound DNA-anti-DNA immune complexesN L Meryhew, J Mukherjee, M S Creager, et al.
Chemical Communications (Cambridge, England)|July 12, 2012
Grafting of chain-end-functionalized perfluorocyclobutyl (PFCB) aryl ether ionomers onto mesoporous carbon supportsJiyoung Park, Jung-Min Oh, Stephen E Creager, et al.
Vascular Medicine (London, England)|March 12, 2021
SVM Communications: Interview with writing committee of Advanced Training Statement on vascular medicine and talking points from Paclitaxel CoalitionDaniella Kadian-Dodov, Mark A Creager, Naomi M Hamburg, et al.
Pageof 71

Showing results (151-160 of 703) with videos related to

Sort By:
Pageof 71
The American Journal of Cardiology|February 14, 2023
Association of Anticoagulation and Major Adverse Limb Events After Index Peripheral Endovascular InterventionNiveditta Ramkumar, Philip P Goodney, Mark A Creager, et al.
European Heart Journal|April 30, 2013
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IIJoshua A Beckman, Francesco Paneni, Francesco Cosentino, et al.
The Journal of Physical Chemistry. B|October 30, 2010
Effect of perfluoroalkyl chain length on proton conduction in fluoroalkylated phosphonic, phosphinic, and sulfonic acidsMahesha B Herath, Stephen E Creager, Alex Kitaygorodskiy, et al.
Circulation|October 1, 2003
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part IIThomas F Lüscher, Mark A Creager, Joshua A Beckman, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|September 24, 2010
Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery diseaseWilliam R Hiatt, Mark A Creager, Antonino Amato, et al.
The New England Journal of Medicine|October 27, 1988
Vascular response in diabetes with neuropathic foot lesionsJ S Stamler, M A Creager, J Loscalzo, et al.
Circulation|October 15, 1995
Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunctionJ M Hare, E Loh, M A Creager, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1992
A kinetic study of factor I-mediated modification and release of RBC-bound DNA-anti-DNA immune complexesN L Meryhew, J Mukherjee, M S Creager, et al.
Chemical Communications (Cambridge, England)|July 12, 2012
Grafting of chain-end-functionalized perfluorocyclobutyl (PFCB) aryl ether ionomers onto mesoporous carbon supportsJiyoung Park, Jung-Min Oh, Stephen E Creager, et al.
Vascular Medicine (London, England)|March 12, 2021
SVM Communications: Interview with writing committee of Advanced Training Statement on vascular medicine and talking points from Paclitaxel CoalitionDaniella Kadian-Dodov, Mark A Creager, Naomi M Hamburg, et al.
Pageof 71